An 84-year-old man left clinicians at a Hong Kong hospital utterly perplexed after arriving at the hospital to be treated […] ...
Epidermolysis Bullosa (EB), or butterfly disease, affects 1 in 50,000 people, causing fragile skin that blisters easily, ...
Argyria is caused by a buildup of silver in the body, which discolors the skin.
Managing the unpredictable symptoms of indolent systemic mastocytosis prompted a search for answers and community.
A fusion protein therapy may be an effective treatment option for cutaneous T-cell lymphomas, according to a multicenter ...
Skinvisible granted Quoin an exclusive, royalty-bearing license to its technology for use in select rare skin diseases and for the right to use its proprietary formula for Netherton Syndrome.
Rutgers Health researchers find that allergy medicine could help patients with a rare genetic disease avoid liver transplants ...
Quoin Pharmaceuticals, a biotech company with a keen focus on rare diseases, has recently been making waves in the world of dermatology with its treatment for Netherton Syndrome. This rare genetic ...
rare skin diseases, rare metabolic disorders, and rare respiratory diseases. In addition, Relief is commercializing several legacy products via licensing and distribution partners. Headquartered ...